search
Back to results

Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project) (Family CARE)

Primary Purpose

Colorectal Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TeleCARE
Pamphlet intervention
Sponsored by
University of Utah
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer focused on measuring Colorectal, Cancer, Colon, Rectal, Behavioral Intervention, Screening, Motivational Interviewing, Extended Parallel Process Model, Implementation Intentions, Family CARE

Eligibility Criteria

30 Years - 74 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Have at least one first-degree relative diagnosed with colorectal cancer (CRC) between the ages of 40-59, or one first-degree relative diagnosed with colorectal cancer at age 40 or older and an additional first-degree or second-degree relative diagnosed with colorectal cancer at age 40 or older.
  • If relative was diagnosed over age 50, participant must be 40-74 years old.
  • If relative was diagnosed at age 40-49, participant cannot be more than ten years younger than relative at first diagnosis (e.g., dx at 48, participant must be 38-74 years old).
  • Colorectal cancer cases of relatives recruited through the cancer registries of California, Colorado, Idaho, New Mexico, or Utah; Rocky Mountain Cancer Genetics Coalition sites of National Cancer Genetics Network in Colorado, New Mexico, or Utah; or Intermountain Health Care

Exclusion Criteria:

  • Previous cancer diagnosis of any kind (except for non-melanoma skin cancers).
  • Has had a colonoscopy within the past five years.
  • Meets clinical criteria for Lynch syndrome or other polyposis syndromes.
  • Has had prior involvement in colorectal cancer-related clinical, behavioral or epidemiologic cancer familial research.
  • Mentally incompetent, incarcerated, hearing or visually impaired.
  • Unable to read and speak English fluently.

Sites / Locations

  • California Cancer Registry
  • University of Colorado Cancer Center
  • Colorado Central Cancer Registry
  • Cancer Data Registry of Idaho
  • University of New Mexico
  • Intermountain Health Care
  • Huntsman Cancer Institute
  • Utah Cancer Registry

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Telephone-delivered risk intervention

Mailed pamphlet intervention group

Arm Description

Participants in this arm receive a personalized telephone-risk assessment intervention provided by a trained cancer risk counselor.

Participants in this group receive a mailed pamphlet containing information about familial colorectal cancer risk and screening.

Outcomes

Primary Outcome Measures

Colonoscopy
The primary outcome is colonoscopy. Medical record verification of self-reported colonoscopy is performed.

Secondary Outcome Measures

Fecal occult blood test (FOBT)/Fecal Immunochemical Test (FIT)
Fecal occult blood test(FOBT) following the intervention. Medical confirmation of self-reported FOBT/FIT is performed.
Perceived Control
The Perceived Personal Control Scale is an integrative outcome that encompasses the broad spectrum of health risk communication and informed decision-making. This validated scale is a 9-item measure representing three dimensions of control participants believe they have regarding family history of colorectal cancer (CRC): cognitive-interpretive, decisional, and behavioral. A 5-point Likert-style response format is used ranging from very little control to very high control. A total scale score is calculated by summing the items.
Perceived Risk
A 4-item scale with established construct and predictive validity with regard to cancer screening will assess participants' subjective perceived risk for developing colorectal cancer. Responses are measured on a five-point Likert scale ranging from very small to very large.
Psychological distress
Generalized psychological distress will be operationalized as state anxiety and we will use the State Subscale of the State Trait Anxiety Inventory. We will also measure cancer-specific distress with the Impact of Event Scale. The stressor in this study is having a family history of colorectal cancer.
Knowledge
The Colorectal Cancer Knowledge Survey is a validated 12-item scale that assesses colorectal cancer screening knowledge, colorectal cancer risk factors (including family history) and CRC symptoms. The questionnaire consists of true/false with a possible range of scores of 0-12. FOBT items will be substituted with colonoscopy.
Decisional Conflict
Participants are asked to evaluate whether or not they feel confident in their decision to receive or not receive CRC screening. Assessment following the intervention will determine whether the decisional conflict has been resolved and whether or not that resolution results in colonoscopy uptake.

Full Information

First Posted
December 10, 2010
Last Updated
April 6, 2016
Sponsor
University of Utah
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT01274143
Brief Title
Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)
Acronym
Family CARE
Official Title
Impact of Remote Familial Colorectal Cancer Assessment and Counseling
Study Type
Interventional

2. Study Status

Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
May 2008 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Utah
Collaborators
National Cancer Institute (NCI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project) is designed to determine whether a personalized telephone plus mailed print cancer risk assessment and behavior change counseling intervention is more effective than a targeted mailed print intervention in promoting risk appropriate screening in individuals with a family history of the disease. The project targets people residing in both rural and urban areas, allowing an examination of differential intervention effects with regard to place of residence.
Detailed Description
The rate of adherence to regular colonoscopy screening (CS) among members of families at increased risk for colorectal cancer (CRC) is far below recommended levels. Persons who live in rural areas of the United States exhibit lower CRC screening rates than their urban counterparts. Although the detection of familial predisposition to cancer begins with an accurate family medical history, data indicate that many patients do not receive adequate familial cancer risk assessment from their primary care providers. This suggests that familial risk is largely unrecognized which may lead to inadequate risk stratification, lack of risk notification, appropriate risk counseling, suboptimal cancer screening and preventable deaths. Because of geographic and system-level barriers, special efforts are needed to improve access to personalized risk communication and adherence to CRC screening to rural and other geographically underserved populations at increased risk for CRC. In the proposed study, we will evaluate a novel telephone-based, theory-guided personalized risk communication intervention that combines a familial CRC risk assessment and behavioral counseling with tailored messages. The key hypothesis guiding this study is that a multifaceted personalized risk communication intervention will improve CS at a significantly higher rate than a mailed targeted print intervention. Our integrative study model specifies important theoretical mechanisms that can contribute to increased use of CS among persons at increased risk. We will enroll 438 adult men and women between the ages of 30-74 who are considered at increased risk of familial CRC into this 2-group randomized trial. The primary aim of this study is to compare colonoscopy use among participants in the two groups. Secondary aims are to compare the two groups with regard to cognitive and emotional outcomes and explore the underlying mechanisms through which the interventions have an impact on colonoscopy behavior. Sociodemographic, clinical, behavioral and psychosocial measures will be collected from participants at baseline, and 1 month, 9 months, and 15 months following the intervention. Self-reported colonoscopy is verified with medical records. The study's findings will have both theoretical, as well as practical significance. Our findings will help to influence the selection and dissemination of effective outreach approaches to improve CRC screening in populations at increased risk for the disease. These results have broad applicability to understanding responses to personalized risk communication interventions for other diseases as well. Findings will also broaden our understanding of the underlying theoretical mechanisms of how remote cancer risk communications lead to improvements in cancer screening among geographically underserved populations if such intervention effects are observed. In addition to studying the intervention effects in rural areas, we will enroll participants in urban areas. These enhancements to our population-based randomized behavioral trial will provide us with an unprecedented opportunity to assess reach and determine if there are differential intervention effects (i.e., efficacy) with regard to place of residence (rurality vs. urbanicity.)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Colorectal, Cancer, Colon, Rectal, Behavioral Intervention, Screening, Motivational Interviewing, Extended Parallel Process Model, Implementation Intentions, Family CARE

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
496 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Telephone-delivered risk intervention
Arm Type
Active Comparator
Arm Description
Participants in this arm receive a personalized telephone-risk assessment intervention provided by a trained cancer risk counselor.
Arm Title
Mailed pamphlet intervention group
Arm Type
Active Comparator
Arm Description
Participants in this group receive a mailed pamphlet containing information about familial colorectal cancer risk and screening.
Intervention Type
Behavioral
Intervention Name(s)
TeleCARE
Intervention Description
Personalized telephone-delivered cancer risk assessment.
Intervention Type
Behavioral
Intervention Name(s)
Pamphlet intervention
Intervention Description
Mailed pamphlet about familial colorectal cancer risk and screening.
Primary Outcome Measure Information:
Title
Colonoscopy
Description
The primary outcome is colonoscopy. Medical record verification of self-reported colonoscopy is performed.
Time Frame
9 month follow-up
Secondary Outcome Measure Information:
Title
Fecal occult blood test (FOBT)/Fecal Immunochemical Test (FIT)
Description
Fecal occult blood test(FOBT) following the intervention. Medical confirmation of self-reported FOBT/FIT is performed.
Time Frame
Baseline, 1 month, 9 month, and 15 month follow-up
Title
Perceived Control
Description
The Perceived Personal Control Scale is an integrative outcome that encompasses the broad spectrum of health risk communication and informed decision-making. This validated scale is a 9-item measure representing three dimensions of control participants believe they have regarding family history of colorectal cancer (CRC): cognitive-interpretive, decisional, and behavioral. A 5-point Likert-style response format is used ranging from very little control to very high control. A total scale score is calculated by summing the items.
Time Frame
Baseline, 1 month and 9 month follow-up
Title
Perceived Risk
Description
A 4-item scale with established construct and predictive validity with regard to cancer screening will assess participants' subjective perceived risk for developing colorectal cancer. Responses are measured on a five-point Likert scale ranging from very small to very large.
Time Frame
Baseline, 1 month and 9 month follow-up
Title
Psychological distress
Description
Generalized psychological distress will be operationalized as state anxiety and we will use the State Subscale of the State Trait Anxiety Inventory. We will also measure cancer-specific distress with the Impact of Event Scale. The stressor in this study is having a family history of colorectal cancer.
Time Frame
Baseline, 1 month and 9 month follow-up
Title
Knowledge
Description
The Colorectal Cancer Knowledge Survey is a validated 12-item scale that assesses colorectal cancer screening knowledge, colorectal cancer risk factors (including family history) and CRC symptoms. The questionnaire consists of true/false with a possible range of scores of 0-12. FOBT items will be substituted with colonoscopy.
Time Frame
Baseline, 1 month and 9 month follow-up
Title
Decisional Conflict
Description
Participants are asked to evaluate whether or not they feel confident in their decision to receive or not receive CRC screening. Assessment following the intervention will determine whether the decisional conflict has been resolved and whether or not that resolution results in colonoscopy uptake.
Time Frame
Baseline, 1 month and 9 month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have at least one first-degree relative diagnosed with colorectal cancer (CRC) between the ages of 40-59, or one first-degree relative diagnosed with colorectal cancer at age 40 or older and an additional first-degree or second-degree relative diagnosed with colorectal cancer at age 40 or older. If relative was diagnosed over age 50, participant must be 40-74 years old. If relative was diagnosed at age 40-49, participant cannot be more than ten years younger than relative at first diagnosis (e.g., dx at 48, participant must be 38-74 years old). Colorectal cancer cases of relatives recruited through the cancer registries of California, Colorado, Idaho, New Mexico, or Utah; Rocky Mountain Cancer Genetics Coalition sites of National Cancer Genetics Network in Colorado, New Mexico, or Utah; or Intermountain Health Care Exclusion Criteria: Previous cancer diagnosis of any kind (except for non-melanoma skin cancers). Has had a colonoscopy within the past five years. Meets clinical criteria for Lynch syndrome or other polyposis syndromes. Has had prior involvement in colorectal cancer-related clinical, behavioral or epidemiologic cancer familial research. Mentally incompetent, incarcerated, hearing or visually impaired. Unable to read and speak English fluently.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anita Y Kinney, Ph.D., R.N.
Organizational Affiliation
Huntsman Cancer Institute and University of Utah
Official's Role
Principal Investigator
Facility Information:
Facility Name
California Cancer Registry
City
Sacramento
State/Province
California
ZIP/Postal Code
95825
Country
United States
Facility Name
University of Colorado Cancer Center
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
Colorado Central Cancer Registry
City
Denver
State/Province
Colorado
ZIP/Postal Code
80246
Country
United States
Facility Name
Cancer Data Registry of Idaho
City
Boise
State/Province
Idaho
ZIP/Postal Code
83701
Country
United States
Facility Name
University of New Mexico
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131
Country
United States
Facility Name
Intermountain Health Care
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84111
Country
United States
Facility Name
Huntsman Cancer Institute
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
Facility Name
Utah Cancer Registry
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
28236077
Citation
Brumbach BH, Birmingham WC, Boonyasiriwat W, Walters S, Kinney AY. Intervention Mediators in a Randomized Controlled Trial to Increase Colonoscopy Uptake Among Individuals at Increased Risk of Familial Colorectal Cancer. Ann Behav Med. 2017 Oct;51(5):694-706. doi: 10.1007/s12160-017-9893-1.
Results Reference
derived
PubMed Identifier
24435063
Citation
Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC, Schwartz MD, Samadder J, Boucher K, Kinney AY. Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics. 2014;17(1):48-60. doi: 10.1159/000356567. Epub 2014 Jan 14.
Results Reference
derived
PubMed Identifier
24307472
Citation
Boonyasiriwat W, Hung M, Hon SD, Tang P, Pappas LM, Burt RW, Schwartz MD, Stroup AM, Kinney AY. Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med. 2014 Jun;47(3):280-91. doi: 10.1007/s12160-013-9562-y.
Results Reference
derived
PubMed Identifier
23782890
Citation
Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY. Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial. Trials. 2013 Apr 30;14:116. doi: 10.1186/1745-6215-14-116.
Results Reference
derived

Learn more about this trial

Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)

We'll reach out to this number within 24 hrs